In the medical industry, hubs of innovation aren’t created overnight. They are cultivated over time, when policymakers, institutions, medical device makers and suppliers collaborate to create an environment with the right infrastructure to support innovation. If you study areas of the world with a high concentration of medical innovation, you’ll find seven things:

• Business-friendly government policies
• Significant regional investment by larger medical device manufacturers
• Access to funding
• Strong educational and research infrastructure
• Availability of qualified personnel
• World class supply chain
• Optimal logistics.

Singapore’s medtech community has all those elements. This whitepaper looks at how these elements are driving rapid innovation in COVID-related invitro device (IVD) technology. Read the fully whitepaper here.